Pan-Trk immunoreactivity is associated with a fusion partner-specific pattern of staining [2] NTRK-rearranged tumours also commonly express CD34, often with coexpression of S100, but lack SOX10 expression [4]. This evidence concerns the gene TPM3 and neoplasm.